Shrimanker, R., Pavord, I., Price, R., Bradford, E., Keene, O., & Yancey, S. (2018). Fractional exhaled nitric oxide and the peripheral blood eosinophil count as biomarkers of the response to mepolizumab in patients with severe eosinophilic asthma. American Thoracic Society.
Цитирование в стиле Чикаго (17-е изд.)Shrimanker, R., I. Pavord, R. Price, E. Bradford, O. Keene, и S. Yancey. Fractional Exhaled Nitric Oxide and the Peripheral Blood Eosinophil Count as Biomarkers of the Response to Mepolizumab in Patients with Severe Eosinophilic Asthma. American Thoracic Society, 2018.
Цитирование MLA (9-е изд.)Shrimanker, R., et al. Fractional Exhaled Nitric Oxide and the Peripheral Blood Eosinophil Count as Biomarkers of the Response to Mepolizumab in Patients with Severe Eosinophilic Asthma. American Thoracic Society, 2018.